{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:55:18Z","timestamp":1794477318162,"version":"4.9.1"},"reference-count":22,"publisher":"BMJ","issue":"12","funder":[{"name":"Spanish Pediatric Emergency Research Group","award":["2019"],"award-info":[{"award-number":["2019"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To evaluate the need for routine urine studies in children with febrile neutropenia with cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>A prospective, observational study was conducted in two hospitals between November 2019 and October 2021.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients<\/jats:title><jats:p>We recruited 205 patients in total.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main outcome measures<\/jats:title><jats:p>The primary outcome was presence of positive urine culture (UC). Urinary tract infection (UTI) was defined as urinary signs\/symptoms and positive UC with or without pyuria. A descriptive analysis of data is provided.<\/jats:p><jats:p>We conducted a prospective study of paediatric patients with cancer with urinary continence. Data were analysed using descriptive statistics. The diagnostic performance of urinalysis was calculated using positive UC as the gold standard.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Positive UC was found in 7 of the 205 patients (3.4%; 95%\u2009CI 1.4% to 6.9%), 2 presenting urinary symptoms. UTI prevalence was 1.0% (95% CI 0.1% to 3.5%). A 23.8% prevalence of positive UC was found in patients with urinary symptoms and\/or history of urinary tract disease (95%\u2009CI 8.2% to 47.2%) as compared with 1.1% of those without symptoms or history (95%\u2009CI 0.1% to 3.9%) (p&lt;0.001). The sensitivity, specificity, negative predictive value, and area under the curve for urinalysis were 16.7% (95% CI 3.0% to 56.4%), 98.4% (95% CI 95.3% to 99.4%), 97.3% (95% CI 93.9% to 98.9%), and 0.65 (95% CI 0.51 to 0.79), respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>UTI is an infrequent cause of infection in these patients. Urinalysis is indicated only in children with febrile neutropenia with urinary signs\/symptoms and in asymptomatic patients with a history of urinary tract disease or unknown history. When urine is collected, UC should be requested regardless of the result of the urinalysis.<\/jats:p><\/jats:sec>","DOI":"10.1136\/archdischild-2023-325992","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T17:20:20Z","timestamp":1691515220000},"page":"982-986","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Role of urine culture in paediatric patients with cancer with fever and neutropenia: a prospective observational study"],"prefix":"10.1136","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7648-1336","authenticated-orcid":false,"given":"Jose Antonio","family":"Alonso-Cadenas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Sancosmed Ron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Lera Carballo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Lassaletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio","family":"Rodrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"de la Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,8,8]]},"reference":[{"key":"2023112404500997000_108.12.982.1","doi-asserted-by":"publisher","DOI":"10.1086\/522533"},{"key":"2023112404500997000_108.12.982.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2004.03.004"},{"key":"2023112404500997000_108.12.982.3","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19960215)77:4<791::AID-CNCR27>3.0.CO;2-V"},{"key":"2023112404500997000_108.12.982.4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.3.919"},{"key":"2023112404500997000_108.12.982.5","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piaa029"},{"key":"2023112404500997000_108.12.982.6","doi-asserted-by":"crossref","unstructured":"Stergiotis M , Ammann RA , Droz S , et al . Pediatric fever in neutropenia with bacteremia-pathogen distribution and in vitro antibiotic susceptibility patterns over time in a retrospective single-center cohort study. PLoS One 2021;16:e0246654. doi:10.1371\/journal.pone.0246654","DOI":"10.1371\/journal.pone.0246654"},{"key":"2023112404500997000_108.12.982.7","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1200\/JCO.22.02224","article-title":"Guideline for the management of fever and neutropenia in pediatric patients with cancer and hematopoietic cell transplantation recipients: 2023 update","volume":"41","author":"Lehrnbecher","year":"2023","journal-title":"JCO"},{"key":"2023112404500997000_108.12.982.8","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw325"},{"key":"2023112404500997000_108.12.982.9","unstructured":"National Institute for Health and Care Excellence . Neutropenic sepsis: prevention and management of neutropenic sepsis in cancer patients. 2012. Available: https:\/\/www.nice.org.uk\/guidance\/cg151 [Accessed 8 Apr 2023]."},{"key":"2023112404500997000_108.12.982.10","doi-asserted-by":"publisher","DOI":"10.1007\/BF00344056"},{"key":"2023112404500997000_108.12.982.11","doi-asserted-by":"publisher","DOI":"10.1086\/502043"},{"key":"2023112404500997000_108.12.982.12","first-page":"136","article-title":"Febrile neutropenia in cancer patients in a tertiary care medical center in Lebanon: microbial spectrum and outcome","volume":"48","author":"Hamzeh","year":"2000","journal-title":"J Med Liban"},{"key":"2023112404500997000_108.12.982.13","doi-asserted-by":"publisher","DOI":"10.3109\/08880018.2011.617809"},{"key":"2023112404500997000_108.12.982.14","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1080\/23744235.2016.1205216","article-title":"Low impact of urine cultures as a diagnostic tool in patients with neutropenic fever","volume":"48","author":"Steinr\u00fccken","year":"2016","journal-title":"Infect Dis (Lond)"},{"key":"2023112404500997000_108.12.982.15","doi-asserted-by":"publisher","DOI":"10.1097\/PEC.0b013e3181d6db37"},{"key":"2023112404500997000_108.12.982.16","doi-asserted-by":"publisher","DOI":"10.1097\/01.PCC.0000149131.72248.E6"},{"key":"2023112404500997000_108.12.982.17","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz021"},{"key":"2023112404500997000_108.12.982.18","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31815e4122"},{"key":"2023112404500997000_108.12.982.19","doi-asserted-by":"crossref","unstructured":"Williams G , Craig JC . Long-term antibiotics for preventing recurrent urinary tract infection in children. Cochrane Database Syst Rev 2019;4:CD001534. doi:10.1002\/14651858.CD001534.pub4","DOI":"10.1002\/14651858.CD001534.pub4"},{"key":"2023112404500997000_108.12.982.20","first-page":"1072","article-title":"Antimicrobial prophylaxis for children with Vesicoureteral reflux","volume":"371","author":"Hoberman","year":"2014","journal-title":"N Engl J Med"},{"key":"2023112404500997000_108.12.982.21","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22799"},{"key":"2023112404500997000_108.12.982.22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.5847\/wjem.j.1920-8642.2021.02.003","article-title":"Role of urine studies in asymptomatic febrile neutropenic patients presenting to the emergency Department","volume":"12","author":"Zgheib","year":"2021","journal-title":"World J Emerg Med"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2023-325992","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T12:53:50Z","timestamp":1700830430000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2023-325992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,8]]},"references-count":22,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,11,17]]},"published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1136\/archdischild-2023-325992"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2023-325992","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,8]]}}}